Literature DB >> 18398265

Age and motor score predict osteoprotegerin level in chronic spinal cord injury.

L R Morse1, H P Nguyen, N Jain, S Williams, C G Tun, R A Battaglino, P Stashenko, E Garshick.   

Abstract

OBJECTIVE: Individuals with spinal cord injury (SCI) develop a severe form of osteoporosis below the level of injury that is poorly understood. We conducted a preliminary investigation to assess whether circulating markers of bone turnover and circulating RANKL/OPG levels are related to the severity of SCI, aging, or to differences in mobility (i.e., walking or using a wheelchair).
METHODS: Sixty-four caucasian men >or=1.6 years since injury selected based on locomotive mode provided blood samples and completed a health questionnaire at the VA Boston Healthcare System from 10/2003 to 6/2005. Plasma sRANKL, osteoprotegerin (OPG), osteocalcin and carboxyterminal telopeptide of type I collagen (CTx) levels were determined.
RESULTS: Increasing age was significantly associated with increased OPG and CTx. Injury severity was predictive of OPG levels, and adjusting for age, participants with cervical motor complete and ASIA C SCI (n=11) had significantly lower mean OPG (46.1 pg/ml) levels than others (63.4 pg/ml). Locomotive mode was not associated with differences in bone markers.
CONCLUSIONS: Severe cervical spinal cord injury is associated with decreased circulating OPG levels placing these patients at risk for accelerated bone loss that appears unrelated to locomotive mode.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398265      PMCID: PMC2365904     

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN: 1108-7161            Impact factor:   2.041


  41 in total

1.  Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats.

Authors:  E L Hill; R Turner; R Elde
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

2.  Longitudinal study of bone turnover after acute spinal cord injury.

Authors:  D Roberts; W Lee; R C Cuneo; J Wittmann; G Ward; R Flatman; B McWhinney; P E Hickman
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Authors:  D L Lacey; E Timms; H L Tan; M J Kelley; C R Dunstan; T Burgess; R Elliott; A Colombero; G Elliott; S Scully; H Hsu; J Sullivan; N Hawkins; E Davy; C Capparelli; A Eli; Y X Qian; S Kaufman; I Sarosi; V Shalhoub; G Senaldi; J Guo; J Delaney; W J Boyle
Journal:  Cell       Date:  1998-04-17       Impact factor: 41.582

4.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Bone mineral density and indexes of bone metabolism in spinal cord injury.

Authors:  S M Szollar; E M Martin; D J Sartoris; J G Parthemore; L J Deftos
Journal:  Am J Phys Med Rehabil       Date:  1998 Jan-Feb       Impact factor: 2.159

6.  Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury.

Authors:  F Biering-Sørensen; H H Bohr; O P Schaadt
Journal:  Eur J Clin Invest       Date:  1990-06       Impact factor: 4.686

7.  Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat.

Authors:  E L Hill; R Elde
Journal:  Cell Tissue Res       Date:  1991-06       Impact factor: 5.249

8.  Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women.

Authors:  E I Barengolts; M Berman; S C Kukreja; T Kouznetsova; C Lin; E V Chomka
Journal:  Calcif Tissue Int       Date:  1998-03       Impact factor: 4.333

9.  Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section.

Authors:  E Wilmet; A A Ismail; A Heilporn; D Welraeds; P Bergmann
Journal:  Paraplegia       Date:  1995-11

10.  Lower extremity fractures after spinal cord injury: a retrospective study.

Authors:  K T Ragnarsson; G H Sell
Journal:  Arch Phys Med Rehabil       Date:  1981-09       Impact factor: 3.966

View more
  5 in total

1.  Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy.

Authors:  L Gifre; S Ruiz-Gaspà; J L Carrasco; E Portell; J Vidal; A Muxi; A Monegal; N Guañabens; P Peris
Journal:  Osteoporos Int       Date:  2017-06-04       Impact factor: 4.507

2.  VA-based survey of osteoporosis management in spinal cord injury.

Authors:  Leslie R Morse; Lora Giangregorio; Ricardo A Battaglino; Robert Holland; B Catharine Craven; Kelly L Stolzmann; Antonio A Lazzari; Sunil Sabharwal; Eric Garshick
Journal:  PM R       Date:  2009-02-06       Impact factor: 2.298

3.  Osteoporotic fractures and hospitalization risk in chronic spinal cord injury.

Authors:  L R Morse; R A Battaglino; K L Stolzmann; L D Hallett; A Waddimba; D Gagnon; A A Lazzari; E Garshick
Journal:  Osteoporos Int       Date:  2008-06-26       Impact factor: 4.507

4.  The Relationship Between Dietary Intakes of Amino Acids and Bone Mineral Density Among Individuals with Spinal Cord Injury.

Authors:  Hadis Sabour; Maryam Nazari; Sahar Latifi; Zahra Soltani; Hania Shakeri; Bagher Larijani; Seyed-Mohammad Ghodsi; Seyed-Hassan Emami Razavi
Journal:  Oman Med J       Date:  2016-01

5.  Prevention and management of osteoporosis and osteoporotic fractures in persons with a spinal cord injury or disorder: A systematic scoping review.

Authors:  Nour Zleik; Frances Weaver; Robert L Harmon; Brian Le; Reshmitha Radhakrishnan; Wanda D Jirau-Rosaly; B Catharine Craven; Mattie Raiford; Jennifer N Hill; Bella Etingen; Marylou Guihan; Michael H Heggeness; Cara Ray; Laura Carbone
Journal:  J Spinal Cord Med       Date:  2018-05-10       Impact factor: 1.985

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.